Barre verticale Université de Lausanne - Unisciences
 
 
Séparateur Annuaire Séparateur Actualités Séparateur Aide Séparateur Login
Langues:  fr | en
Transparent
RECHERCHE
Transparent
Transparent
Transparent
Photo ambiance
UNIL > Unisciences >
MyUNIL
Transparent
AFFICHER LES DONNEES
Transparent
à
Données actuelles
Transparent

Pascal Schneider

Coordonnées Enseignements Publications  

Publications

Articles

Smulski C.R., Beyrath J., Decossas M., Chekkat N., Wolff P., Estieu-Gionnet K., Guichard G., Speiser D., Schneider P., Fournel S., Cysteine-rich Domain 1 of CD40 Mediates Receptor Self-assembly. Journal of Biological Chemistry 288(15), pp. 10914-10922, 2013. [DOI] [Web of Science] [Pubmed]

Nys J., Smulski C.R., Tardivel A., Willen L., Kowalczyk C., Donzé O., Huard B., Hess H., Schneider P., No Evidence That Soluble TACI Induces Signalling via Membrane-Expressed BAFF and APRIL in Myeloid Cells. PLoS One 8(4), p. e61350, 2013. [DOI] [Web of Science] [Pubmed]

Pellegrini M., Willen L., Perroud M., Krushinskie D., Strauch K., Cuervo H., Day E.S., Schneider P., Zheng T.S., Structure of the extracellular domains of human and Xenopus Fn14: implications in the evolution of TWEAK and Fn14 interactions. FEBS Journal 280(8), pp. 1818-1829, 2013. [DOI] [Web of Science] [Pubmed]

Kong M., Muñoz N., Valdivia A., Alvarez A., Herrera-Molina R., Cárdenas A., Schneider P., Burridge K., Quest A.F., Leyton L., Thy-1-mediated cell-cell contact induces astrocyte migration through the engagement of αVβ3 integrin and syndecan-4. Biochimica et Biophysica Acta. Molecular Cell Research 1833(6), pp. 1409-1420, 2013. [DOI] [Web of Science] [Pubmed]

Zhang N., Wang X., Huo Q., Li X., Wang H., Schneider P., Hu G., Yang Q., The Oncogene Metadherin Modulates the Apoptotic Pathway Based on the Tumor Necrosis Factor Superfamily Member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in Breast Cancer. Journal of Biological Chemistry 288(13), pp. 9396-9407, 2013. [DOI] [Web of Science] [Pubmed]

Schmiedel B.J., Nuebling T., Steinbacher J., Malinovska A., Wende C.M., Azuma M., Schneider P., Grosse-Hovest L., Salih H.R., Receptor activator for NF-κB ligand in acute myeloid leukemia: expression, function, and modulation of NK cell immunosurveillance. Journal of Immunology 190(2), pp. 821-831, 2013. [DOI] [Web of Science] [Pubmed]

Schmiedel B.J., Scheible C.A., Nuebling T., Kopp H.G., Wirths S., Azuma M., Schneider P., Jung G., Grosse-Hovest L., Salih H.R., RANKL expression, function, and therapeutic targeting in multiple myeloma and chronic lymphocytic leukemia. Cancer Research 73(2), pp. 683-694, 2013. [DOI] [Web of Science] [Pubmed]

Tanos T., Sflomos G., Echeverria P.C., Ayyanan A., Gutierrez M., Delaloye J.F., Raffoul W., Fiche M., Dougall W., Schneider P. et al., Progesterone/RANKL is a major regulatory axis in the human breast. Science Translational Medicine 5(182), p. 182ra55, 2013. [DOI] [Web of Science] [Pubmed] ok

Smith W., Tomasec P., Aicheler R., Loewendorf A., Nemčovičová I., Wang E.C., Stanton R.J., Macauley M., Norris P., Willen L. et al., Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses. Cell Host and Microbe 13(3), pp. 324-335, 2013. [DOI] [Web of Science] [Pubmed]

Heinz L.X., Rebsamen M., Rossi D.C., Staehli F., Schroder K., Quadroni M., Gross O., Schneider P., Tschopp J., The death domain-containing protein Unc5CL is a novel MyD88-independent activator of the pro-inflammatory IRAK signaling cascade. Cell Death and Differentiation 19(4), pp. 722-731, 2012. [DOI] [Web of Science] [Pubmed]

Voutilainen M., Lindfors P.H., Lefebvre S., Ahtiainen L., Fliniaux I., Rysti E., Murtoniemi M., Schneider P., Schmidt-Ullrich R., Mikkola M.L., Ectodysplasin regulates hormone-independent mammary ductal morphogenesis via NF-κB. Proceedings of the National Academy of Sciences of the United States of America 109(15), pp. 5744-5749, 2012. [DOI] [Web of Science] [Pubmed] ok

Herrera-Molina R., Frischknecht R., Maldonado H., Seidenbecher C.I., Gundelfinger E.D., Hetz C., Aylwin Mde L, Schneider P., Quest A.F., Leyton L., Astrocytic αVβ3 integrin inhibits neurite outgrowth and promotes retraction of neuronal processes by clustering Thy-1. PLoS One 7(3), p. e34295, 2012. [DOI] [Web of Science] [Pubmed]

Lefebvre S., Fliniaux I., Schneider P., Mikkola M.L., Identification of ectodysplasin target genes reveals the involvement of chemokines in hair development. Journal of Investigative Dermatology 132(4), pp. 1094-1102, 2012. [DOI] [Web of Science] [Pubmed]

Kimberley F.C., van der Sloot A.M., Guadagnoli M., Cameron K., Schneider P., Marquart J.A., Versloot M., Serrano L., Medema J.P., The design and characterization of receptor-selective APRIL variants. Journal of Biological Chemistry 287(44), pp. 37434-37446, 2012. [DOI] [Web of Science] [Pubmed]

Drexler S.K., Bonsignore L., Masin M., Tardivel A., Jackstadt R., Hermeking H., Schneider P., Gross O., Tschopp J., Yazdi A.S., Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 109(45), pp. 18384-18389, 2012. [DOI] [Web of Science] [Pubmed]

Ganeff C., Remouchamps C., Boutaffala L., Benezech C., Galopin G., Vandepaer S., Bouillenne F., Ormenese S., Chariot A., Schneider P. et al., Induction of the alternative NF-κB pathway by lymphotoxin αβ (LTαβ) relies on internalization of LTβ receptor. Molecular and Cellular Biology 31(21), pp. 4319-4334, 2011. [DOI] [Web of Science] [Pubmed]

Boeglin E., Smulski C.R., Brun S., Milosevic S., Schneider P., Fournel S., Toll-like receptor agonists synergize with CD40L to induce either proliferation or plasma cell differentiation of mouse B cells. PLoS One 6(10), p. e25542, 2011. [DOI] [Web of Science] [Pubmed]

Kowalczyk C., Dunkel N., Willen L., Casal M.L., Mauldin E.A., Gaide O., Tardivel A., Badic G., Etter A.L., Favre M. et al., Molecular and therapeutic characterization of anti-ectodysplasin A receptor (EDAR) agonist monoclonal antibodies. Journal of Biological Chemistry 286(35), pp. 30769-30779, 2011. [DOI] [Web of Science] [Pubmed]

Turchinovich G., Vu T.T., Frommer F., Kranich J., Schmid S., Alles M., Loubert J.B., Goulet J.P., Zimber-Strobl U., Schneider P. et al., Programming of marginal zone B-cell fate by basic Kruppel-like factor (BKLF/KLF3). Blood 117(14), pp. 3780-3792, 2011. [DOI] [Web of Science] [Pubmed]

Bossen C., Tardivel A., Willen L., Fletcher C.A., Perroud M., Beermann F., Rolink A.G., Scott M.L., Mackay F., Schneider P., Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses. European Journal of Immunology 41(3), pp. 787-797, 2011. [DOI] [Web of Science] [Pubmed]

Henríquez M., Herrera-Molina R., Valdivia A., Alvarez A., Kong M., Muñoz N., Eisner V., Jaimovich E., Schneider P., Quest A.F. et al., ATP release due to Thy-1-integrin binding induces P2X7-mediated calcium entry required for focal adhesion formation. Journal of Cell Science 124(Pt 9), pp. 1581-1588, 2011. [DOI] [Web of Science] [Pubmed]

Bacchelli C., Buckland K.F., Buckridge S., Salzer U., Schneider P., Thrasher A.J., Gaspar H.B., The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice. Journal of Allergy and Clinical Immunology 127(5), pp. 1253-9.e13, 2011. [DOI] [Web of Science] [Pubmed]

Fuertes Marraco S.A., Scott C.L., Bouillet P., Ives A., Masina S., Vremec D., Jansen E.S., O'Reilly L.A., Schneider P., Fasel N. et al., Type I interferon drives dendritic cell apoptosis via multiple BH3-only proteins following activation by PolyIC in vivo. PLoS One 6(6), p. e20189, 2011. [DOI] [Web of Science] [Pubmed]

Michaelson J.S., Amatucci A., Kelly R., Su L., Garber E., Day E.S., Berquist L., Cho S., Li Y., Parr M. et al., Development of an Fn14 agonistic antibody as an anti-tumor agent. mAbs 3(4), pp. 362-375, 2011. [DOI] [Pubmed]

Beleut M., Rajaram R.D., Caikovski M., Ayyanan A., Germano D., Choi Y., Schneider P., Brisken C., Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proceedings of the National Academy of Sciences of the United States of America 107(7), pp. 2989-2994, 2010. [DOI] [Web of Science] [Pubmed] ok

Mues G., Tardivel A., Willen L., Kapadia H., Seaman R., Frazier-Bowers S., Schneider P., D'Souza R.N., Functional analysis of Ectodysplasin-A mutations causing selective tooth agenesis. European Journal of Human Genetics 18(1), pp. 19-25, 2010. [Document] [DOI] [Web of Science] [Pubmed] ok

Swee L.K., Tardivel A., Schneider P., Rolink A., Rescue of the mature B cell compartment in BAFF-deficient mice by treatment with recombinant Fc-BAFF. Immunology Letters 131(1), pp. 40-48, 2010. [Document] [DOI] [Web of Science] [Pubmed] ok

Kassahn D., Nachbur U., Conus S., Micheau O., Schneider P., Simon H.U., Brunner T., Distinct requirements for activation-induced cell surface expression of preformed Fas/CD95 ligand and cytolytic granule markers in T cells. Cell Death and Differentiation 16(1), pp. 115-124, 01-2009. [DOI] [Web of Science] [Pubmed] ok

Willett B.J., McMonagle E.L., Logan N., Schneider P., Hosie M.J., Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus. Molecular Immunology 46(6), pp. 1020-1030, 2009. [DOI] [Web of Science] [Pubmed] ok

Salzer U., Bacchelli C., Buckridge S., Pan-Hammarström Q., Jennings S., Lougaris V., Bergbreiter A., Hagena T., Birmelin J., Plebani A. et al., Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 113(9), pp. 1967-1976, 2009. [DOI] [Web of Science] [Pubmed] ok

Guarda G., Dostert C., Staehli F., Cabalzar K., Castillo R., Tardivel A., Schneider P., Tschopp J., T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 460(7252), pp. 269-273, 2009. [DOI] [Web of Science] [Pubmed] ok

Back J., Malchiodi E.L., Cho S., Scarpellino L., Schneider P., Kerzic M.C., Mariuzza R.A., Held W., Distinct conformations of Ly49 natural killer cell receptors mediate MHC class I recognition in trans and cis. Immunity 31(4), pp. 598-608, 2009. [DOI] [Web of Science] [Pubmed] ok

Bessa J., Jegerlehner A., Hinton H.J., Pumpens P., Saudan P., Schneider P., Bachmann M.F., Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses. Journal of Immunology 183(6), pp. 3788-3799, 2009. [DOI] [Pubmed] ok

Avalos A.M., Valdivia A.D., Muñoz N., Herrera-Molina R., Tapia J.C., Lavandero S., Chiong M., Burridge K., Schneider P., Quest A.F. et al., Neuronal Thy-1 induces astrocyte adhesion by engaging syndecan-4 in a cooperative interaction with alphavbeta3 integrin that activates PKCalpha and RhoA. Journal of Cell Science 122(Pt 19), pp. 3462-3471, 2009. [DOI] [Web of Science] [Pubmed]

Mauldin E.A., Gaide O., Schneider P., Casal M.L., Neonatal treatment with recombinant ectodysplasin prevents respiratory disease in dogs with X-linked ectodermal dysplasia. American Journal of Medical Genetics. Part A 149A(9), pp. 2045-2049, 2009. [DOI] [Web of Science] [Pubmed]

Swee L.K., Ingold-Salamin K., Tardivel A., Willen L., Gaide O., Favre M., Demotz S., Mikkola M., Schneider P., Biological activity of ectodysplasin A is conditioned by its collagen and heparan sulfate proteoglycan-binding domains. Journal of Biological Chemistry 284(40), pp. 27567-27576, 10-2009. [Document] [DOI] [Pubmed] ok

Vince J.E., Chau D., Callus B., Wong W.W., Hawkins C.J., Schneider P., McKinlay M., Benetatos C.A., Condon S.M., Chunduru S.K. et al., TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. Journal of Cell Biology 182(1), pp. 171-184, 2008. [DOI] [Web of Science] [Pubmed] ok

Bossen C., Cachero T.G., Tardivel A., Ingold K., Willen L., Dobles M., Scott M.L., Maquelin A., Belnoue E., Siegrist C.A. et al., TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood 111(3), pp. 1004-1012, 2008. [DOI] [Web of Science] [Pubmed] ok

Hermosilla T., Muñoz D., Herrera-Molina R., Valdivia A., Muñoz N., Nham S.U., Schneider P., Burridge K., Quest A.F., Leyton L., Direct Thy-1/alphaVbeta3 integrin interaction mediates neuron to astrocyte communication. Biochimica et Biophysica Acta-Molecular Cell Research 1783(6), pp. 1111-1120, 06-2008. [DOI] [Web of Science] [Pubmed] ok

Huard B., McKee T., Bosshard C., Durual S., Matthes T., Myit S., Donze O., Frossard C., Chizzolini C., Favre C. et al., APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. Journal of Clinical Investigation 118(8), pp. 2887-2895, 2008. [DOI] [Web of Science] [Pubmed] ok

Pappu B.P., Borodovsky A., Zheng T.S., Yang X., Wu P., Dong X., Weng S., Browning B., Scott M.L., Ma L. et al., TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. Journal of Experimental Medicine 205(5), pp. 1049-1062, 05-2008. [DOI] [Web of Science] [Pubmed] ok

Massacand J.C., Kaiser P., Ernst B., Tardivel A., Bürki K., Schneider P., Harris N.L., Intestinal bacteria condition dendritic cells to promote IgA production. PLoS ONE 3(7), p. e2588, 2008. [Document] [DOI] [Web of Science] [Pubmed] ok

Farley S.M., Purdy D.E., Ryabinina O.P., Schneider P., Magun B.E., Iordanov M.S., Fas ligand-induced proinflammatory transcriptional responses in reconstructed human epidermis. Recruitment of the epidermal growth factor receptor and activation of MAP kinases. Journal of Biological Chemistry 283(2), pp. 919-928, 2008. [Document] [DOI] [Web of Science] [Pubmed]

Tu W., Lau Y.L., Zheng J., Liu Y., Chan P.L., Mao H., Dionis K., Schneider P., Lewis D.B., Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells. Blood 112(6), pp. 2554-62, 09-2008. [Document] [DOI] [Web of Science] [Pubmed] ok

Belnoue E., Pihlgren M., McGaha T.L., Tougne C., Rochat A.F., Bossen C., Schneider P., Huard B., Lambert P.H., Siegrist C.A., APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 111(5), pp. 2755-2764, 2008. [Document] [DOI] [Web of Science] [Pubmed]

Pummila M., Fliniaux I., Jaatinen R., James M.J., Laurikkala J., Schneider P., Thesleff I., Mikkola M.L., Ectodysplasin has a dual role in ectodermal organogenesis: inhibition of Bmp activity and induction of Shh expression. Development 134(1), pp. 117-125, 2007. [Document] [DOI] [Web of Science] [Pubmed] ok

Casal M.L., Lewis J.R., Mauldin E.A., Tardivel A., Ingold K., Favre M., Paradies F., Demotz S., Gaide O., Schneider P., Significant correction of disease after postnatal administration of recombinant ectodysplasin A in canine X-linked ectodermal dysplasia. American Journal of Human Genetics 81(5), pp. 1050-1056, 2007. [Document] [DOI] [Web of Science] [Pubmed]

Kummer J.A., Micheau O., Schneider P., Bovenschen N., Broekhuizen R., Quadir R., Strik M.C., Hack C.E., Tschopp J., Ectopic expression of the serine protease inhibitor PI9 modulates death receptor-mediated apoptosis. Cell Death and Differentiation 14(8), pp. 1486-1496, 2007. [Document] [DOI] [Web of Science] [Pubmed]

Schwaller J., Schneider P., Mhawech-Fauceglia P., McKee T., Myit S., Matthes T., Tschopp J., Donze O., Le Gal F.A., Huard B., Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness. Blood 109(1), pp. 331-338, 2007. [Document] [DOI] [Web of Science] [Pubmed] ok

Kothlow S., Morgenroth I., Graef Y., Schneider K., Riehl I., Staeheli P., Schneider P., Kaspers B., Unique and conserved functions of B cell-activating factor of the TNF family (BAFF) in the chicken. International Immunology 19(2), pp. 203-215, 2007. [Document] [DOI] [Web of Science] [Pubmed]

Willett B.J., McMonagle E.L., Logan N., Spiller O.B., Schneider P., Hosie M.J., Probing the interaction between feline immunodeficiency virus and CD134 by using the novel monoclonal antibody 7D6 and the CD134 (Ox40) ligand. Journal of Virology 81(18), pp. 9665-9679, 2007. [Document] [DOI] [Web of Science] [Pubmed]

Vince J.E., Wong W.W., Khan N., Feltham R., Chau D., Ahmed A.U., Benetatos C.A., Chunduru S.K., Condon S.M., McKinlay M. et al., IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 131(4), pp. 682-693, 2007. [Document] [DOI] [Web of Science] [Pubmed]

Bossen C., Ingold K., Tardivel A., Bodmer J.L., Gaide O., Hertig S., Ambrose C., Tschopp J., Schneider P., Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. Journal of Biological Chemistry 281(20), pp. 13964-13971, 2006. [Document] [DOI] [Web of Science] [Pubmed]

Corazza N., Jakob S., Schaer C., Frese S., Keogh A., Stroka D., Kassahn D., Torgler R., Mueller C., Schneider P. et al., TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. Journal of Clinical Investigation 116(9), pp. 2493-2499, 2006. [Document] [DOI] [Web of Science] [Pubmed] ok

Farley S.M., Dotson A.D., Purdy D.E., Sundholm A.J., Schneider P., Magun B.E., Iordanov M.S., Fas ligand elicits a caspase-independent proinflammatory response in human keratinocytes: implications for dermatitis. Journal of Investigative Dermatology 126(11), pp. 2438-2451, 2006. [Document] [DOI] [Web of Science] [Pubmed] ok

Schmidt-Ullrich R., Tobin D.J., Lenhard D., Schneider P., Paus R., Scheidereit C., NF-kappaB transmits Eda A1/EdaR signalling to activate Shh and cyclin D1 expression, and controls post-initiation hair placode down growth. Development 133(6), pp. 1045-1057, 2006. [Document] [DOI] [Web of Science] [Pubmed]

Mou C., Jackson B., Schneider P., Overbeek P.A., Headon D.J., Generation of the primary hair follicle pattern. Proceedings of the National Academy of Sciences of the United States of America 103(24), pp. 9075-9080, 2006. [Document] [DOI] [Web of Science] [Pubmed] ok

Mérino D., Lalaoui N., Morizot A., Schneider P., Solary E., Micheau O., Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. Molecular and Cellular Biology 26(19), pp. 7046-7055, 2006. [Document] [DOI] [Web of Science] [Pubmed] ok

Cachero T.G., Schwartz I.M., Qian F., Day E.S., Bossen C., Ingold K., Tardivel A., Krushinskie D., Eldredge J., Silvian L. et al., Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor). Biochemistry 45(7), pp. 2006-2013, 2006. [Document] [DOI] [Web of Science] [Pubmed]

Girgenrath M., Weng S., Kostek C.A., Browning B., Wang M., Brown S.A., Winkles J.A., Michaelson J.S., Allaire N., Schneider P. et al., TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO Journal 25(24), pp. 5826-5839, 2006. [Document] [DOI] [Web of Science] [Pubmed]

Ingold K., Zumsteg A., Tardivel A., Huard B., Steiner Q.G., Cachero T.G., Qiang F., Gorelik L., Kalled S.L., Acha-Orbea H. et al., Identification of proteoglycans as the APRIL-specific binding partners. Journal of Experimental Medicine 201(9), pp. 1375-1383, 2005. [Document] [DOI] [Web of Science] [Pubmed]

Iordanov M.S., Ryabinina O.P., Schneider P., Magun B.E., Two mechanisms of caspase 9 processing in double-stranded RNA- and virus-triggered apoptosis. Apoptosis 10(1), pp. 153-166, 2005. [Document] [DOI] [Web of Science] [Pubmed]

Cebecauer M., Guillaume P., Hozák P., Mark S., Everett H., Schneider P., Luescher I.F., Soluble MHC-peptide complexes induce rapid death of CD8+ CTL. Journal of immunology 174(11), pp. 6809-6819, 2005. [Document] [Web of Science] [Pubmed] ok

Fournel S., Wieckowski S., Sun W., Trouche N., Dumortier H., Bianco A., Chaloin O., Habib M., Peter J.C., Schneider P. et al., C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L. Nature Chemical Biology 1(7), pp. 377-382, 2005. [Document] [DOI] [Web of Science] [Pubmed]

Kvell K., Nguyen T.H., Salmon P., Glauser F., Werner-Favre C., Barnet M., Schneider P., Trono D., Zubler R.H., Transduction of CpG DNA-stimulated primary human B cells with bicistronic lentivectors. Molecular Therapy 12(5), pp. 892-899, 2005. [Document] [DOI] [Web of Science] [Pubmed]

Legler D.F., Doucey M.A., Schneider P., Chapatte L., Bender F.C., Bron C., Differential insertion of GPI-anchored GFPs into lipid rafts of live cells. FASEB Journal 19(1), pp. 73-75, 2005. [Document] [DOI] [Web of Science] [Pubmed]

Pleskoff O., Casarosa P., Verneuil L., Ainoun F., Beisser P., Smit M., Leurs R., Schneider P., Michelson S., Ameisen J.C., The human cytomegalovirus-encoded chemokine receptor US28 induces caspase-dependent apoptosis. FEBS Journal 272(16), pp. 4163-4177, 2005. [Document] [DOI] [Web of Science] [Pubmed]

Iordanov M.S., Sundholm A.J., Simpson E.L., Hanifin J.M., Ryabinina O.P., Choi R.J., Korcheva V.B., Schneider P., Magun B.E., Cell death-induced activation of epidermal growth factor receptor in keratinocytes: implications for restricting epidermal damage in dermatitis. Journal of Investigative Dermatology 125(1), pp. 134-142, 2005. [Document] [DOI] [Web of Science] [Pubmed]

Salzer U., Chapel H.M., Webster A.D., Pan-Hammarström Q., Schmitt-Graeff A., Schlesier M., Peter H.H., Rockstroh J.K., Schneider P., Schäffer A.A. et al., Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nature Genetics 37(8), pp. 820-828, 2005. [Document] [DOI] [Web of Science] [Pubmed]

Avalos A.M., Arthur W.T., Schneider P., Quest A.F., Burridge K., Leyton L., Aggregation of integrins and RhoA activation are required for Thy-1-induced morphological changes in astrocytes. Journal of Biological Chemistry 279(37), pp. 39139-39145, 2004. [DOI] [Web of Science] [Pubmed]

Schneider K., Kothlow S., Schneider P., Tardivel A., Göbel T., Kaspers B., Staeheli P., Chicken BAFF--a highly conserved cytokine that mediates B cell survival. International Immunology 16(1), pp. 139-148, 2004. [DOI] [Web of Science] [Pubmed]

Batten M., Fletcher C., Ng L.G., Groom J., Wheway J., Laâbi Y., Xin X., Schneider P., Tschopp J., Mackay C.R. et al., TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. Journal of Immunology 172(2), pp. 812-822, 2004. [Web of Science] [Pubmed]

Huard B., Arlettaz L., Ambrose C., Kindler V., Mauri D., Roosnek E., Tschopp J., Schneider P., French L.E., BAFF production by antigen-presenting cells provides T cell co-stimulation. International Immunology 16(3), pp. 467-475, 2004. [DOI] [Web of Science] [Pubmed]

Mustonen T., Ilmonen M., Pummila M., Kangas A.T., Laurikkala J., Jaatinen R., Pispa J., Gaide O., Schneider P., Thesleff I. et al., Ectodysplasin A1 promotes placodal cell fate during early morphogenesis of ectodermal appendages. Development 131(20), pp. 4907-4919, 2004. [Document] [DOI] [Web of Science] [Pubmed]

Tardivel A., Tinel A., Lens S., Steiner Q.G., Sauberli E., Wilson A., Mackay F., Rolink A.G., Beermann F., Tschopp J. et al., The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF. European Journal of Immunology 34(2), pp. 509-518, 2004. [Document] [DOI] [Web of Science] [Pubmed]

Brunetti C.R., Paulose-Murphy M., Singh R., Qin J., Barrett J.W., Tardivel A., Schneider P., Essani K., McFadden G., A secreted high-affinity inhibitor of human TNF from Tanapox virus. Proceedings of the National Academy of Sciences of the United States of America 100(8), pp. 4831-4836, 2003. [DOI] [Web of Science] [Pubmed]

Küenzi P., Schneider P., Dobbelaere D.A., Theileria parva-transformed T cells show enhanced resistance to Fas/Fas ligand-induced apoptosis. Journal of Immunology 171(3), pp. 1224-1231, 2003. [Web of Science] [Pubmed]

Holler N., Tardivel A., Kovacsovics-Bankowski M., Hertig S., Gaide O., Martinon F., Tinel A., Deperthes D., Calderara S., Schulthess T. et al., Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Molecular and Cellular Biology 23(4), pp. 1428-1440, 2003. [Document] [DOI] [Web of Science] [Pubmed]

Schneider P., Olson D., Tardivel A., Browning B., Lugovskoy A., Gong D., Dobles M., Hertig S., Hofmann K., Van Vlijmen H. et al., Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Journal of Biological Chemistry 278(7), pp. 5444-5454, 2003. [Document] [DOI] [Web of Science] [Pubmed]

Gaide O., Schneider P., Permanent correction of an inherited ectodermal dysplasia with recombinant EDA. Nature Medicine 9(5), pp. 614-618, 2003. [Document] [DOI] [Web of Science] [Pubmed]

Lowin-Kropf B., Kunz B., Schneider P., Held W., A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors. European Journal of Immunology 32(3), pp. 773-782, 2002. [DOI] [Web of Science] [Pubmed] ok

Strik M.C., Bladergroen B.A., Wouters D., Kisiel W., Hooijberg J.H., Verlaan A.R., Hordijk P.L., Schneider P., Hack C.E., Kummer J.A., Distribution of the human intracellular serpin protease inhibitor 8 in human tissues. Journal of Histochemistry and Cytochemistry 50(11), pp. 1443-1454, 2002. [Web of Science] [Pubmed]

Petit F., Arnoult D., Lelièvre J.D., Moutouh-de Parseval L., Hance A.J., Schneider P., Corbeil J., Ameisen J.C., Estaquier J., Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell death. Journal of Biological Chemistry 277(2), pp. 1477-1487, 2002. [DOI] [Web of Science] [Pubmed]

Micheau O., Thome M., Schneider P., Holler N., Tschopp J., Nicholson D.W., Briand C., Grütter M.G., The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. Journal of Biological Chemistry 277(47), pp. 45162-45171, 2002. [DOI] [Web of Science] [Pubmed]

Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., Tschopp J., Cachero T.G., Batten M., Wheway J. et al., Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. Journal of Clinical Investigation 109(1), pp. 59-68, 2002. [DOI] [Web of Science] [Pubmed]

Rolink A.G., Tschopp J., Schneider P., Melchers F., BAFF is a survival and maturation factor for mouse B cells. European Journal of Immunology 32(7), pp. 2004-2010, 2002. [DOI] [Web of Science] [Pubmed]

Leyton L., Schneider P., Labra C.V., Rüegg C., Hetz C.A., Quest A.F., Bron C., Thy-1 binds to integrin beta(3) on astrocytes and triggers formation of focal contact sites. Current Biology 11(13), pp. 1028-1038, 2001. [DOI] [Web of Science] [Pubmed]

Werner-Favre C., Bovia F., Schneider P., Holler N., Barnet M., Kindler V., Tschopp J., Zubler R.H., IgG subclass switch capacity is low in switched and in IgM-only, but high in IgD+IgM+, post-germinal center (CD27+) human B cells. European Journal of Immunology 31(1), pp. 243-249, 2001. [DOI] [Web of Science] [Pubmed]

Lecossier D., Bouchonnet F., Schneider P., Clavel F., Hance A.J., Centre de Recherche Integré sur le VIH Bichat-Claude Bernard, Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of changes in thymic output and T cell death. Journal of Infectious Diseases 183(7), pp. 1009-1016, 2001. [DOI] [Web of Science] [Pubmed]

Houimel M., Schneider P., Terskikh A., Mach J.P., Selection of peptides and synthesis of pentameric peptabody molecules reacting specifically with ErbB-2 receptor. International Journal of Cancer 92(5), pp. 748-755, 2001. [DOI] [Web of Science] [Pubmed]

Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., Hession C., Schneider P., Sizing I.D., Mullen C. et al., BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293(5537), pp. 2108-2111, 2001. [DOI] [Web of Science] [Pubmed]

Huard B., Schneider P., Mauri D., Tschopp J., French L.E., T cell costimulation by the TNF ligand BAFF. Journal of Immunology 167(11), pp. 6225-6231, 2001. [Web of Science] [Pubmed]

Schneider P., Street S.L., Gaide O., Hertig S., Tardivel A., Tschopp J., Runkel L., Alevizopoulos K., Ferguson B.M., Zonana J., Mutations leading to X-linked hypohidrotic ectodermal dysplasia affect three major functional domains in the tumor necrosis factor family member ectodysplasin-A. Journal of Biological Chemistry 276(22), pp. 18819-18827, 2001. [Document] [DOI] [Web of Science] [Pubmed]

Schneider P., Takatsuka H., Wilson A., Mackay F., Tardivel A., Lens S., Cachero T.G., Finke D., Beermann F., Tschopp J., Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. Journal of Experimental Medicine 194(11), pp. 1691-1697, 2001. [Document] [DOI] [Web of Science] [Pubmed]

Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., Browning J.L., Mackay F., BAFF mediates survival of peripheral immature B lymphocytes. Journal of Experimental Medicine 192(10), pp. 1453-1466, 2000. [DOI] [Web of Science] [Pubmed]

Tucker A.S., Headon D.J., Schneider P., Ferguson B.M., Overbeek P., Tschopp J., Sharpe P.T., Edar/Eda interactions regulate enamel knot formation in tooth morphogenesis. Development 127(21), pp. 4691-4700, 2000. [Web of Science] [Pubmed]

Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., Bodmer J.L., Schneider P., Seed B., Tschopp J., Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunology 1(6), pp. 489-495, 2000. [DOI] [Web of Science] [Pubmed]

Rochat-Steiner V., Becker K., Micheau O., Schneider P., Burns K., Tschopp J., FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation. Journal of Experimental Medicine 192(8), pp. 1165-1174, 2000. [DOI] [Web of Science] [Pubmed]

Bodmer J.L., Holler N., Reynard S., Vinciguerra P., Schneider P., Juo P., Blenis J., Tschopp J., TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nature Cell Biology 2(4), pp. 241-243, 2000. [DOI] [Web of Science] [Pubmed]

Rennert P., Schneider P., Cachero T.G., Thompson J., Trabach L., Hertig S., Holler N., Qian F., Mullen C., Strauch K. et al., A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. Journal of Experimental Medicine 192(11), pp. 1677-1684, 2000. [DOI] [Web of Science] [Pubmed]

Thompson J.S., Schneider P., Kalled S.L., Wang L., Lefevre E.A., Cachero T.G., MacKay F., Bixler S.A., Zafari M., Liu Z.Y. et al., BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. Journal of Experimental Medicine 192(1), pp. 129-135, 2000. [DOI] [Web of Science] [Pubmed]

Mühlenbeck F., Schneider P., Bodmer J.L., Schwenzer R., Hauser A., Schubert G., Scheurich P., Moosmayer D., Tschopp J., Wajant H., The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation. Journal of Biological Chemistry 275(41), pp. 32208-32213, 2000. [DOI] [Web of Science] [Pubmed]

Bodmer J.L., Meier P., Tschopp J., Schneider P., Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL. Journal of Biological Chemistry 275(27), pp. 20632-20637, 2000. [Document] [DOI] [Web of Science] [Pubmed]

Holler N., Kataoka T., Bodmer J.L., Romero P., Romero J., Deperthes D., Engel J., Tschopp J., Schneider P., Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors. Journal of Immunological Methods 237(1-2), pp. 159-173, 2000. [Document] [DOI] [Web of Science] [Pubmed]

Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., Tschopp J., Browning J.L., Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. Journal of Experimental Medicine 190(11), pp. 1697-1710, 1999. [DOI] [Web of Science] [Pubmed]

Benedict C.A., Butrovich K.D., Lurain N.S., Corbeil J., Rooney I., Schneider P., Tschopp J., Ware C.F., Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. Journal of Immunology 162(12), pp. 6967-6970, 1999. [Web of Science] [Pubmed]

Thome M., Martinon F., Hofmann K., Rubio V., Steiner V., Schneider P., Mattmann C., Tschopp J., Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappaB transcription factor and c-Jun N-terminal kinase. Journal of Biological Chemistry 274(15), pp. 9962-9968, 1999. [DOI] [Web of Science] [Pubmed]

Corradin S., Ransijn A., Corradin G., Roggero M.A., Schmitz A.A., Schneider P., Mauël J., Vergères G., MARCKS-related protein (MRP) is a substrate for the Leishmania major surface protease leishmanolysin (gp63). Journal of Biological Chemistry 274(36), pp. 25411-25418, 1999. [DOI] [Web of Science] [Pubmed]

Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H. et al., BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. Journal of Experimental Medicine 189(11), pp. 1747-1756, 1999. [Document] [DOI] [Web of Science] [Pubmed]

Schneider P., Schwenzer R., Haas E., Mühlenbeck F., Schubert G., Scheurich P., Tschopp J., Wajant H., TWEAK can induce cell death via endogenous TNF and TNF receptor 1. European Journal of Immunology 29(6), pp. 1785-1792, 1999. [Document] [DOI] [Web of Science] [Pubmed]

Treumann A., Güther M.L., Schneider P., Ferguson M.A., Analysis of the carbohydrate and lipid components of glycosylphosphatidylinositol structures. Methods in Molecular Biology 76, pp. 213-235, 1998. [DOI] [Pubmed]

Hahne M., Kataoka T., Schröter M., Hofmann K., Irmler M., Bodmer J.L., Schneider P., Bornand T., Holler N., French L.E. et al., APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. Journal of Experimental Medicine 188(6), pp. 1185-1190, 1998. [DOI] [Web of Science] [Pubmed]

Viard I., Wehrli P., Bullani R., Schneider P., Holler N., Salomon D., Hunziker T., Saurat J.H., Tschopp J., French L.E., Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282(5388), pp. 490-493, 1998. [DOI] [Web of Science] [Pubmed]

Kataoka T., Schröter M., Hahne M., Schneider P., Irmler M., Thome M., Froelich C.J., Tschopp J., FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation. Journal of Immunology 161(8), pp. 3936-3942, 1998. [Web of Science] [Pubmed]

Burns K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer J.L., Di Marco F., French L., Tschopp J., MyD88, an adapter protein involved in interleukin-1 signaling. Journal of Biological Chemistry 273(20), pp. 12203-12209, 1998. [DOI] [Web of Science] [Pubmed]

Eberl G., Jiang S., Yu Z., Schneider P., Corradin G., Mach J.P., An anti-CD19 antibody coupled to a tetanus toxin peptide induces efficient Fas ligand (FasL)-mediated cytotoxicity of a transformed human B cell line by specific CD4+ T cells. Clinical and Experimental Immunology 114(2), pp. 173-178, 1998. [DOI] [Web of Science] [Pubmed] ok

Schneider P., Holler N., Bodmer J.L., Hahne M., Frei K., Fontana A., Tschopp J., Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. Journal of Experimental Medicine 187(8), pp. 1205-1213, 1998. [Document] [DOI] [Web of Science] [Pubmed]

Becker K., Schneider P., Hofmann K., Mattmann C., Tschopp J., Interaction of Fas(Apo-1/CD95) with proteins implicated in the ubiquitination pathway. FEBS Letters 412(1), pp. 102-106, 1997. [DOI] [Web of Science] [Pubmed]

Bodmer J.L., Burns K., Schneider P., Hofmann K., Steiner V., Thome M., Bornand T., Hahne M., Schröter M., Becker K. et al., TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6(1), pp. 79-88, 1997. [DOI] [Web of Science] [Pubmed]

Thome M., Schneider P., Hofmann K., Fickenscher H., Meinl E., Neipel F., Mattmann C., Burns K., Bodmer J.L., Schröter M. et al., Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386(6624), pp. 517-521, 1997. [Document] [DOI] [Web of Science] [Pubmed]

Schneider P., Thome M., Burns K., Bodmer J.L., Hofmann K., Kataoka T., Holler N., Tschopp J., TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 7(6), pp. 831-836, 1997. [Document] [DOI] [Web of Science] [Pubmed]

Schneider P., Bodmer J.L., Thome M., Hofmann K., Holler N., Tschopp J., Characterization of two receptors for TRAIL. FEBS letters 416(3), pp. 329-34, 1997. [Document] [DOI] [Web of Science] [Pubmed] ok

Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J.L., Schröter M., Burns K., Mattmann C. et al., Inhibition of death receptor signals by cellular FLIP. Nature 388(6638), pp. 190-195, 1997. [Document] [DOI] [Web of Science] [Pubmed]

Schneider P., Bodmer J.L., Holler N., Mattmann C., Scuderi P., Terskikh A., Peitsch M.C., Tschopp J., Characterization of Fas (Apo-1, CD95)-Fas ligand interaction. Journal of Biological Chemistry 272(30), pp. 18827-18833, 1997. [Document] [DOI] [Web of Science] [Pubmed]

Hahne M., Rimoldi D., Schröter M., Romero P., Schreier M., French L.E., Schneider P., Bornand T., Fontana A., Lienard D. et al., Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 274(5291), pp. 1363-1366, 1996. [DOI] [Web of Science] [Pubmed]

Proudfoot L., Schneider P., Ferguson M.A., McConville M.J., Biosynthesis of the glycolipid anchor of lipophosphoglycan and the structurally related glycoinositolphospholipids from Leishmania major. Biochemical Journal 308 ( Pt 1)(1), pp. 45-55, 1995. [Web of Science] [Pubmed]

Redman C.A., Schneider P., Mehlert A., Ferguson M.A., The glycoinositol-phospholipids of Phytomonas. Biochemical Journal 311(2), pp. 495-503, 1995. [Web of Science] [Pubmed]

Treumann A., Lifely M.R., Schneider P., Ferguson M.A., Primary structure of CD52. Journal of Biological Chemistry 270(11), pp. 6088-6099, 1995. [Web of Science] [Pubmed]

Rolland L., Belkaid M., Seye A., Schneider P., Gentilini M., Detection of serum antibodies against Leishmania 94 kDa antigen in visceral and cutaneous leishmaniosis due to Leishmania infantum. Parasite 2(1), pp. 13-21, 1995. [Web of Science] [Pubmed]

Schneider P., Nikolaev A., Ferguson M.A., The biosynthesis of GDP-D-arabinopyranose in Crithidia fasciculata: characterization of a D-arabino-1-kinase activity and its use in the synthesis of GDP-[5-3H]D-arabinopyranose. Biochemical Journal 311(1), pp. 307-315, 1995. [Web of Science] [Pubmed]

McConville M.J., Schnur L.F., Jaffe C., Schneider P., Structure of Leishmania lipophosphoglycan: inter- and intra-specific polymorphism in Old World species. Biochemical Journal 310 ( Pt 3)(3), pp. 807-818, 1995. [Web of Science] [Pubmed]

Sacks D.L., Pimenta P.F., McConville M.J., Schneider P., Turco S.J., Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan. Journal of Experimental Medicine 181(2), pp. 685-697, 1995. [DOI] [Web of Science] [Pubmed]

Schneider P., Ferguson M.A., Microscale analysis of glycosylphosphatidylinositol structures. Methods in Enzymology 250, pp. 614-630, 1995. [Web of Science] [Pubmed]

Bouvier J., Schneider P., Etges R., Leishmanolysin: surface metalloproteinase of Leishmania. Methods in Enzymology 248, pp. 614-633, 1995. [Web of Science] [Pubmed]

Buchmüller-Rouiller Y., Corrandin S.B., Smith J., Schneider P., Ransijn A., Jongeneel C.V., Mauël J., Role of glutathione in macrophage activation: effect of cellular glutathione depletion on nitrite production and leishmanicidal activity. Cellular Immunology 164(1), pp. 73-80, 1995. [DOI] [Web of Science] [Pubmed]

Schneider P., McConville M.J., Ferguson M.A., Characterization of GDP-alpha-D-arabinopyranose, the precursor of D-Arap in Leishmania major lipophosphoglycan. Journal of Biological Chemistry 269(28), pp. 18332-18337, 1994. [Web of Science] [Pubmed]

Schneider P., Schnur L.F., Jaffe C.L., Ferguson M.A., McConville M.J., Glycoinositol-phospholipid profiles of four serotypically distinct Old World Leishmania strains. Biochemical Journal 304 ( Pt 2)(2), pp. 603-609, 1994. [Web of Science] [Pubmed]

McConville M.J., Schneider P., Proudfoot L., Masterson C., Ferguson M.A., The developmental regulation and biosynthesis of GPI-related structures in Leishmania parasites. Brazilian Journal of Medical and Biological Research 27(2), pp. 139-144, 1994. [Web of Science] [Pubmed]

Schneider P., Ralton J.E., McConville M.J., Ferguson M.A., Analysis of the neutral glycan fractions of glycosyl-phosphatidylinositols by thin-layer chromatography. Analytical Biochemistry 210(1), pp. 106-112, 1993. [DOI] [Web of Science] [Pubmed]

Schneider P., Glaser T.A., Characterisation of two soluble metalloexopeptidases in the protozoan parasite Leishmania major. Molecular and Biochemical Parasitology 62(2), pp. 223-231, 1993. [DOI] [Web of Science] [Pubmed]

Bouvier J., Schneider P., Malcolm B., A fluorescent peptide substrate for the surface metalloprotease of Leishmania. Experimental Parasitology 76(2), pp. 146-155, 1993. [DOI] [Web of Science] [Pubmed]

Schneider P., Glaser T.A., Characterization of a surface metalloprotease from Herpetomonas samuelpessoai and comparison with Leishmania major promastigote surface protease. Molecular and Biochemical Parasitology 58(2), pp. 277-282, 1993. [DOI] [Web of Science] [Pubmed]

McConville M.J., Collidge T.A., Ferguson M.A., Schneider P., The glycoinositol phospholipids of Leishmania mexicana promastigotes. Evidence for the presence of three distinct pathways of glycolipid biosynthesis. Journal of Biological Chemistry 268(21), pp. 15595-15604, 1993. [Web of Science] [Pubmed]

Schneider P., Rosat J.P., Ransijn A., Ferguson M.A., McConville M.J., Characterization of glycoinositol phospholipids in the amastigote stage of the protozoan parasite Leishmania major. Biochemical Journal 295(2), pp. 555-564, 1993. [Web of Science] [Pubmed]

Ramsden J.J., Schneider P., Membrane insertion and antibody recognition of a glycosylphosphatidylinositol-anchored protein: an optical study. Biochemistry 32(2), pp. 523-529, 1993. [DOI] [Web of Science] [Pubmed]

Schneider P., Rosat J.P., Bouvier J., Louis J., Bordier C., Leishmania major: differential regulation of the surface metalloprotease in amastigote and promastigote stages. Experimental Parasitology 75(2), pp. 196-206, 1992. [DOI] [Web of Science] [Pubmed]

Buchmüller-Rouiller Y., Schneider P., Betz-Corradin S., Smith J., Mauël J., 3-amino-1,2,4-triazole inhibits macrophage NO synthase. Biochemical and Biophysical Research Communications 183(1), pp. 150-155, 1992. [DOI] [Web of Science] [Pubmed]

Bouvier J., Schneider P., Etges R., Bordier C., Peptide substrate specificity of the membrane-bound metalloprotease of Leishmania. Biochemistry 29(43), pp. 10113-10119, 1990. [DOI] [Web of Science] [Pubmed]

Schneider P., Ferguson M.A., McConville M.J., Mehlert A., Homans S.W., Bordier C., Structure of the glycosyl-phosphatidylinositol membrane anchor of the Leishmania major promastigote surface protease. Journal of Biological Chemistry 265(28), pp. 16955-16964, 1990. [Web of Science] [Pubmed]

Articles - Editoriaux

McConville M.J., Schneider P., Conservation of surface molecules in the trypanosomatids. Parasitology Today 9(9), pp. 316-317, 1993. [DOI] [Web of Science] [Pubmed]

Articles - Lettres

Schneider P., Huard B., Buffy's, B-cells, and membrane BAFF. Arthritis & Rheumatism 62(5), pp. 1557-1558, 2010. [Document] [DOI] [Web of Science]

Narasimamurthy R., Geuking P., Ingold K., Willen L., Schneider P., Basler K., Structure-function analysis of Eiger, the Drosophila TNF homolog. Cell Research 19(3), pp. 392-394, 02-2009. [DOI] [Web of Science] [Pubmed] ok

Roosnek E., Schneider P., Huard B., Heparan sulfate proteoglycans, Fc receptors, and DC suppression. Blood 112(3), pp. 915-6; author reply 916-7, 08-2008. [DOI] [Web of Science] [Pubmed] ok

Articles - Synthèses (review)

del Rio M.L., Schneider P., Fernandez-Renedo C., Perez-Simon J.A., Rodriguez-Barbosa J.I., LIGHT/HVEM/LTβR interaction as a target for the modulation of the allogeneic immune response in transplantation. American Journal of Transplantation 13(3), pp. 541-551, 2013. [DOI] [Web of Science] [Pubmed]

Tappy L., Egli L., Lecoultre V., Schneider P., Effects of fructose-containing caloric sweeteners on resting energy expenditure and energy efficiency: a review of human trials. Nutrition and Metabolism 10(1), p. 54, 2013. [DOI] [Web of Science] [Pubmed]

Mackay F., Schneider P., Cracking the BAFF code. Nature reviews. Immunology 9(7), pp. 491-502, 2009. [Document] [DOI] [Web of Science] [Pubmed] ok

Mackay F., Schneider P., TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. Cytokine and Growth Factor Reviews 19(3-4), pp. 263-276, 2008. [DOI] [Web of Science] [Pubmed]

Bossen C., Schneider P., BAFF, APRIL and their receptors: structure, function and signaling. Seminars in Immunology 18(5), pp. 263-275, 2006. [Document] [DOI] [Web of Science] [Pubmed]

Schneider P., The role of APRIL and BAFF in lymphocyte activation. Current Opinion in Immunology 17(3), pp. 282-289, 2005. [Document] [DOI] [Web of Science] [Pubmed]

Mackay F., Schneider P., Rennert P., Browning J., BAFF AND APRIL: a tutorial on B cell survival. Annual Review of Immunology 21, pp. 231-264, 2003. [DOI] [Web of Science] [Pubmed]

Schneider P., Tschopp J., BAFF and the regulation of B cell survival. Immunology Letters 88(1), pp. 57-62, 2003. [DOI] [Web of Science] [Pubmed]

Bodmer J.L., Schneider P., Tschopp J., The molecular architecture of the TNF superfamily. Trends in Biochemical Sciences 27(1), pp. 19-26, 2002. [Document] [DOI] [Web of Science] [Pubmed]

Schneider P., Production of recombinant TRAIL and TRAIL receptor: Fc chimeric proteins. Methods in Enzymology 322, pp. 325-345, 2000. [Web of Science] [Pubmed]

Schneider P., Tschopp J., Apoptosis induced by death receptors. Pharmaceutica Acta Helvetiae 74(2-3), pp. 281-286, 2000. [Pubmed]

Schneider P., Tschopp J., Modulation of death receptor signalling. Symposia of the Society for Experimental Biology 52, pp. 31-42, 2000. [Pubmed]

Schneider P., Bordier C., Etges R., Membrane proteins and enzymes of Leishmania. Sub-cellular Biochemistry 18, pp. 39-72, 1992. [Pubmed]

Parties de livre

Parties de livre - Chapitres

Schneider P., The beautiful structures of BAFF, APRIL and their receptors. In: Cancro M.P. (eds.) BLyS ligands and receptors. Contemporary Immunology, Humana Press, Totowa, NJ, pp. 1-18, 2010. [Document] [url site éditeur] [DOI]

Guichard G., Trouche N., Wieckowski S., Sun W., Chaloin O., Bianco A., Hoebeke J., Schneider P., Fournel S., Rationally-designed multivalent architectures for mimicking homotrimers of CD40L, a member of the TNF superfamily. In: Del Valle S., Escher E., Lubell W.D. (eds.) Peptides for youth. Advances in experimental medicine and biology 611(7), Springer, New York, pp. 355-357, 2009. [DOI] [Web of Science] [Pubmed] ok

Schneider P., Signaling by TNF and related ligands. In: Epstein C., Erickson R., Wynshaw-Boris A. (eds.) Inborn Errors of Development. 2nd edition, Oxford monographs on medical genetics 54, Oxford University Press, Oxford, pp. 433-441, 2008.

Thèses (doctorat)

Das D, Characterisation of heteromers and oligomers in the TNF family of ligands and receptors., Université de Lausanne, Faculté de biologie et médecine, Schneider, P. (dir.), 134 p., 2012. [Document]

Bossen C., Mechanisms of B cell survival induced by BAFF, APRIL and their receptors., Université de Lausanne, Faculté de biologie et médecine, Schneider P. (dir.), 206 p., 2008.

ok : Revue avec comité de lecture

Transparent     Swiss University
Unicentre  -  CH-1015 Lausanne  -  Suisse  -  Tél. +41 21 692 11 11  -  Fax +41 21 692 20 15